A combined immune and exosome-related risk signature as prognostic biomakers in acute myeloid leukemia
Objectives Acute myeloid leukemia (AML) is one of the common hematological diseases with low survival rates. Studies have highlighted the dysregulated expression of immune-related and exosome-related genes (ERGs) in cancers. Nevertheless, it remains to be determined whether combining these genes hav...
Main Authors: | Zenghui Fang, Jiali Fu, Xin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Hematology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2023.2300855 |
Similar Items
-
Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia
by: Wandi Wang, et al.
Published: (2024-01-01) -
Prognostic insights and immune microenvironment delineation in acute myeloid leukemia by ferroptosis-derived signature
by: Lijun Jing, et al.
Published: (2024-03-01) -
Prognostic Significance of Flow Cytometric Immunophenotyping in Patients with Acute Myeloid Leukemia
by: Sinan DEMİRCİOĞLU, et al.
Published: (2022-08-01) -
An immune-related gene prognostic index for acute myeloid leukemia associated with regulatory T cells infiltration
by: Qiongni Xie, et al.
Published: (2022-12-01) -
Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia
by: Yao Xue, et al.
Published: (2019-01-01)